Последние исследования

EudraCT Number: 2004-000541-38 Sponsor Protocol Number: CRAD001A2403 Start Date: 2004-09-27
Sponsor Name: NOVARTIS FARMA
Full Title: A Six-month, Multicenter, Randomized, Open-label Study of the Safety, Tolerability and Efficacy of Two Neoral Doses in addition to Certican 61668; and Steroids in de novo Heart Transplant Recipients.
Medical condition: Prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. It should be used in combination with ciclosporin for mic...
Disease: Version SOC Term Classification Code Term Level
6.1 10056409 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2005-003083-36 Sponsor Protocol Number: NS-SICH Start Date: 2004-09-27
Sponsor Name: OSPEDALE POLICLINICO S. MATTEO
Full Title: Efficacy and safety of factor VIIa eptacog alfa, Novoseven on rebleeding after surgery for spontaneous supratentorial intracerebral, hemorrhage. A randomized, controlled, open-label, investigator...
Medical condition: prevention of re-bleeding after surgery for spontaneous supratentorial intracerebral hemarrage.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-001277-25 Sponsor Protocol Number: ST1472-DM-03-004 Start Date: 2004-09-27
Sponsor Name: SIGMA-TAU
Full Title: A Phase III, Multicentre, Double Blinded Study in Patients with Chronic Hepatitis C who are Non-responders to prior PEGinterferon alpha + Ribavirin Therapy Comparing Treatment with Thymosin alpha 1...
Medical condition: Treatment of Patients with Chronic Hepatitis C who are Non-responders to a course with approved doses of PEGinterferon alpha + Ribavirin
Disease: Version SOC Term Classification Code Term Level
14.1 10021881 - Infections and infestations 10019744 Hepatitis C PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Ongoing) DE (Ongoing) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-005998-29 Sponsor Protocol Number: ICGHCL 2004 Start Date: 2004-09-26
Sponsor Name: AZIENDA OSPEDALIERA SENESE
Full Title: FIVE- VERSUS SEVEN-DAY SUBCUTANEOUS ADMINISTRATION OF CLADRIBINE IN HAIRY CELL LEUKEMIA
Medical condition: Patients with histologically verified HCL classical HCL presence of HCs in the bone marrow and in the peripheral blood detected by positive TRAP staining and positive DBA44 and/or co-expression o...
Disease: Version SOC Term Classification Code Term Level
10019053 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000443-17 Sponsor Protocol Number: NV-02B-011 Start Date: 2004-09-26
Sponsor Name: Idenix Pharmaceuticals, Inc.
Full Title: A Randomized, Double-Blind Trial of Telbivudine (LdT) versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
Medical condition: Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing) LV (Completed)
Trial results: View results
EudraCT Number: 2004-001900-12 Sponsor Protocol Number: PFD-ESC Start Date: 2004-09-26
Sponsor Name: SERVICIO DE PSIQUIATRIA. HOSPITAL UNIVERSITARI VALL D'HEBRON
Full Title: ENSAYO CLINICA DOBLE CIEGO, ALEATORIZADO Y PARALELO SOBRE EL EFECTO DE ESCITALOPRAM vs REBOXETINA EN LA SENSIBILIDAD SOMATICA Y VISCERAL EN PACIENTES CON TRASTORNO DEPRESIVO MAYOR
Medical condition: Trastorno depresivo mayor
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-000971-33 Sponsor Protocol Number: A4061010 Start Date: 2004-09-24
Sponsor Name: PFIZER
Full Title: Randomized, Placebo-Controlled, Double-Blind, Phase 2 Study of AG-013736 in Combination With Docetaxel Versus Docetaxel Alone in Patients With Metastatic Breast Cancer Preceded by a Phase 1 Evaluat...
Medical condition: METASTATIC BREAST CANCER
Disease: Version SOC Term Classification Code Term Level
6.1 10055113 PT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IT (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2004-000940-26 Sponsor Protocol Number: CASM981C2314 Start Date: 2004-09-24
Sponsor Name: Novartis Pharma
Full Title: A 22-week randomized, multicenter, parallel-group, double-blind study to compare a pimecrolimus 1 % (Elidel) twice daily (b.i.d.) maintenance dosing regimen to a once daily (o.d.) maintenance dosin...
Medical condition: Atopic dermatitis
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: FI (Completed) AT (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2004-000022-75 Sponsor Protocol Number: CV131-169 Start Date: 2004-09-24
Sponsor Name: Bristol-Myers Squibb International Corporation
Full Title: Irbesartan Versus Placebo in Combination with Standard Cardiovascular Protection ACE-I Therapy with Ramipril for the Treatment of Albuminuria in Hypertensive Subjects at Elevated Cardiovascular Risk
Medical condition: Albuminuria in hypertensive subjects at increased cardiovascular risk.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed) LV (Completed) IT (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2004-001731-28 Sponsor Protocol Number: C LF 23-0121 0401 Start Date: 2004-09-24
Sponsor Name: FOURNIER Laboratories Ireland
Full Title: A double-blind, 3-arm study on weight loss with combination of micronised fenofibrate 267 mg and metformin 1700 mg per day compared to metformin 1700 mg and placebo, at 6 months, in obese patients,...
Medical condition: Obesity
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: View results

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться